Evidence map›Paper›PMID 31402804›Full record

ArticleMedical archives (Sarajevo, Bosnia and Herzegovina)2019

Lasik as a Solution for High Hypermetropia.

Alma Biscevic, Ajla Pidro, Melisa Ahmedbegovic Pjano, Senad Grisevic, Nina Ziga, Maja Bohac

Abstract read
In one paragraph

Article in Medical archives (Sarajevo, Bosnia and Herzegovina), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
0.9field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 19 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Hyperopic keratorefractive lenticule extraction.Journal of cataract and refractive surgery · 2026
    Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Alma BiscevicEye Clinic "Svjetlost Sarajevo", Sarajevo, Bosnia and Herzegovina.
Ajla PidroEye Clinic "Svjetlost Sarajevo", Sarajevo, Bosnia and Herzegovina.
Melisa Ahmedbegovic PjanoEye Clinic "Svjetlost Sarajevo", Sarajevo, Bosnia and Herzegovina.
Senad GrisevicEye Clinic "Svjetlost Sarajevo", Sarajevo, Bosnia and Herzegovina.
Nina ZigaEye Clinic "Svjetlost Sarajevo", Sarajevo, Bosnia and Herzegovina.
Maja BohacUniversity Eye Clinic "Svjetlost" Zagreb, Zagreb, Croatia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimTo evaluate safety and efficacy of Laser in situ Keratomileusis (LASIK) procedure for the correction of high hypermetropia.

methodsRetrospective study of 160 patients (266 eyes) who underwent LASIK procedure for the correction of hypermetropia between +3.00 and +7.00 diopters(D) and cylinder up to 2.00D from January 2013 and August 2015. All ablations were performed with Wavelight Allegretto Eye-Q400Hzexcimer laser (Alcon, Forth Worth, TX, USA) with aberration free module and were centered on a corneal vertex. All flaps were made with Moria M2 (Moria, Antony, France) mechanical microkeratome (90μm head). Preoperative and postoperative uncorrected and corrected distant visual acuity (UDVA, CDVA), spherical equivalent (SE) and a berrometry for 5mm pupil were measured. Measurements were taken at 1 week, 1,3,6 and 12 months after the surgery. Wilcoxon Signed Ranks Test was used for statistical analysis.

resultsPostoperative UDVA was lower than preoperative CDVA at 1 week(

conclusionLASIK for high hypermetropia showed satisfactory results in postoperative refraction with reasonable regression without significant loss of lines of visual acuity. However, more test are necessary to asses optical quality.

Indexed as

Keratomileusis, Laser In SituVisual AcuityAdultAgedFemaleHumansHyperopiaMaleMiddle AgedPostoperative PeriodPreoperative PeriodRefraction, OcularRetrospective StudiesTime FactorsYoung AdultHypermetropiaLASIKrefractive surgery

Identifiers

PMID31402804
PMCPMC6643362
OpenAlexW2989578191

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.